Scott A. Larson, MD, PhD

Many patients are admitted and readmitted to acute care hospitals with alcohol‐related diagnoses, including alcohol withdrawal syndrome (AWS), and experience significant morbidity and mortality. In patients with septic shock or at risk for acute respiratory distress syndrome (ARDS), chronic alcohol abuse is associated with increased ARDS and severity of multiple organ dysfunction.1 Among intensive care unit (ICU) patients, those with alcohol dependence have higher morbidity, including septic shock, and higher hospital mortality.2 Patients who experience AWS as a result of alcohol dependence may experience life‐threatening complications, such as seizures and delirium tremens.3,4 In‐hospital mortality from AWS is historically high,5 but with benzodiazepines used in a symptom‐driven manner to treat the complications of alcohol use, hospital mortality rates are more recently reported at 2.4%.6

As inpatient outcomes1,2,7 and hospital mortality810 are negatively affected by alcohol abuse, the post‐hospital course of these patients is also of interest. Specifically, patients are often admitted and readmitted with alcohol‐related diagnoses or AWS to acute care hospitals, but relatively little quantitative data exist on readmission factors in this population.11 Patients readmitted to detoxification units or alcohol and substance abuse units have been studied, and factors associated with readmission include psychiatric disorder,1217 female gender,14,15 and delay in rehabilitation aftercare.18

These results cannot be generalized to patients with AWS who are admitted and readmitted to acute‐care hospitals. First, patients hospitalized for alcohol withdrawal symptoms are often medically ill with more severe symptoms, and more frequent coexisting medical and psychiatric illnesses, that complicate the withdrawal syndrome. Detoxification units and substance abuse units require patients to be medically stable before admission, because they do not have the ability to provide a high level of supervision and treatment. Second, much of what we know regarding risk factors for readmission to detoxification centers and substance abuse units comes from studies of administrative data of the Veterans Health Administration,12,13 Medicare Provider Analysis and Review file,16 privately owned outpatient substance abuse centers,14 and publicly funded detoxification centers.18 These results may be difficult to generalize to other patient populations. Accordingly, the objective of this study was to identify demographic and clinical factors associated with multiple admissions to a general medicine service for treatment of AWS over a 3‐year period. Characterization of these high‐risk patients and their hospital course may help focus intervention and reduce these revolving door admissions.

METHODS

The Mayo Clinic Institutional Review Board deemed the study exempt.

Patient Selection

The study was conducted at an 1157‐bed academic tertiary referral hospital, located in the Midwest, that has approximately 15,000 inpatient admissions to general medicine services annually and serves as the main referral center for the region. Patients included in this study were adults admitted to general medicine services and treated with symptom‐triggered Clinical Institute Withdrawal AssessmentAlcohol Revised (CIWA‐Ar) protocol19 between January 1, 2006 and December 31, 2008. Patients were identified using the Mayo Clinic Quality Improvement Resource Center database, as done in a previous CIWA‐Ar study.20 Patients were excluded if the primary diagnosis was a nonalcohol‐related diagnosis (Figure 1).

Figure 1

Patients were placed in 1 of 2 groups based on number of admissions during the study period, either a single‐admission group or a multiple‐admissions group. While most readmission studies use a 30‐day mark from discharge, we used 3 years to better capture relapse and recidivism in this patient population. The 2 groups were then compared retrospectively. To insure that a single admission was not arbitrarily created by the December 2008 cutoff, we reviewed the single‐admission group for additional admissions through June of 2009. If a patient did have a subsequent admission, then the patient was moved to the multiple‐admissions group.

RESULTS

The CIWA‐Ar protocol was ordered on 1199 admissions during the study period. Of these, 411 (34.3%) admissions were excluded because AWS was not the primary diagnosis, leaving 788 (65.7%) admissions for 322 patients, which formed the study population. Of the 322 patients, 180 (56%) had a single admission and 142 (44%) had multiple admissions.

Univariate analyses of demographic and clinical variables are shown in Tables 1 and 2, respectively. Patients with multiple admissions were more likely divorced (P = 0.028), have a high school education or less (P = 0.002), have a higher CCI score (P < 0.0001), a higher CIWA‐Ar score (max) (P < 0.0001), a higher ALT level (P = 0.050), more psychiatric comorbidity (P < 0.026), and a positive urine drug screen (P < 0.001). Adverse events were not significantly different between the 2 groups (Table 2).

Multivariate logistic model analysis was performed using the variables age, male gender, divorced marital status, high school education or less, CIWA‐Ar score (max), CCI score, psychiatric comorbidity, and positive urine drug screen. With a stepwise elimination process, the final model showed that multiple admissions were associated with high school education or less (P = 0.0071), higher CCI score (P = 0.0010), higher CIWA‐Ar score (max) (P < 0.0001), a positive urine drug screen (P = 0.0002), and psychiatric comorbidity (P = 0.0303) (Table 3).

DISCUSSION

We provide important information regarding identification of individuals at high risk for multiple admissions to general medicine services for treatment of AWS. This study found that patients with multiple admissions for AWS had more medical comorbidity. They had more cases of diabetes mellitus, cardiovascular disease, and cerebrovascular disease, and their CCI scores were higher. They also had higher CIWA‐Ar (max) scores, as well as higher CIWA‐Ar component scores, indicating a more severe withdrawal.

Further, psychiatric comorbidity was also associated with multiple admissions. Consistent with the high prevalence in alcoholic patients, psychiatric comorbidity was common in both patients with a single admission and multiple admissions. We also found that a positive urine drug screen was associated with multiple admissions. Interestingly, few patients in each group had a diagnosis recorded in the medical record of an additional substance abuse disorder, yet 14% of patients with a single admission and 29% of patients with multiple admissions had a positive urine drug screen for a non‐alcohol substance. Psychiatric comorbidity, including additional substance abuse, is a well‐established risk factor for readmission to detoxification centers.1215, 17,22,23 Also, people with either an alcohol or non‐alcohol drug addiction, are known to be 7 times more likely to have another addiction than the rest of the population.24 This study suggests clinicians may underrecognize additional substance abuse disorders which are common in this patient population.

In contrast to studies of patients readmitted to detoxification units and substance abuse units,14,15,18,22 we found level of education, specifically a high school education or less, to be associated with multiple admissions. In a study of alcoholics, Greenfield and colleagues found that lower education in alcoholics predicts shorter time to relapse.25 A lack of education may result in inadequate healthcare literacy. Poor health behavior choices that follow may lead to relapse and subsequent admissions for AWS. With respect to other demographic variables, patients in our study population were predominantly men, which is not surprising. Gender differences in alcoholism are well established, with alcohol abuse and dependence more prevalent in men.26 We did not find gender associated with multiple admissions.

Our findings have management and treatment implications. First, providers who care for patients with AWS should not simply focus on treating withdrawal signs and symptoms, but also screen for and address other medical issues, which may not be apparent or seem stable at first glance. While a comorbid medical condition may not be the primary reason for hospital admission, comorbid medical conditions are known to be a source of psychological distress27 and have a negative effect on abstinence. Second, all patients should be screened for additional substance abuse. Initial laboratory testing should include a urine drug screen. Third, before discharging the patient, providers should establish primary care follow‐up for continued surveillance of medical issues. There is evidence that primary care services are predictive of better substance abuse treatment outcomes for those with medical problems.28,29

Finally, inpatient psychiatric consultation, upon admission, is essential for several reasons. First, the psychiatric team can help with initial management and treatment of the alcohol withdrawal regardless of stage and severity, obtain a more comprehensive psychiatric history, and assess for the presence of psychiatric comorbidities that may contribute to, aggravate, or complicate the clinical picture. The team can also address other substance abuse issues when detected by drug screen or clinical history. The psychiatric team, along with chemical‐dependency counselors and social workers, can provide valuable input regarding chemical‐dependency resources available on discharge and help instruct the patient in healthy behaviors. Because healthcare illiteracy may be an issue in this patient population, these instructions should be tailored to the patient's educational level. Prior to discharge, the psychiatry team, social workers, or chemical‐dependency counselors can also assist with, or arrange, rehabilitation aftercare for patients. Recent work shows that patients were less likely to be readmitted to crisis detoxification if they entered rehabilitation care within 3 days of discharge.18

Our study has significant limitations. This study was performed with data at a single academic medical center with an ethnically homogeneous patient population, limiting the external validity of its results. Because this is a retrospective study, data analyses are limited by the quality and accuracy of data in the electronic medical record. Also, our follow‐up period may not have been long enough to detect additional admissions, and we did not screen for patient admissions prior to the study period. By limiting data collection to admissions for AWS to general medical services, we may have missed cases of AWS when admitted for other reasons or to subspecialty services, and we may have missed severe cases requiring admission to an intensive care unit. While we believe we were able to capture most admissions, we may underreport this number since we cannot account for those events that may have occurred at other facilities and locations. Lastly, without a control group, this study is limited in its ability to show an association between any variable and readmission.

In our study, 142 patients accounted for 608 admissions during the 3‐year study period, which speaks to the high recidivism rates for patients with AWS. This disease is associated with high morbidity, high medical costs, and high utilization of healthcare. Our study provides insight regarding identification of patients at high risk of multiple admissions with respect to demographic (lower level of education) and clinical characteristics (worse withdrawal severity, more medical and psychiatric comorbidity, and polysubstance abuse). We believe collaboration between social services, chemical‐dependency counselors, psychiatry, and medicine is necessary to effectively treat this population of patients and assist with the crucial transition to the outpatient setting. Future studies should include key social factors, such as health literacy in the readmission risk assessment, as well as primary care follow‐up and rehabilitation aftercare.

Many patients are admitted and readmitted to acute care hospitals with alcohol‐related diagnoses, including alcohol withdrawal syndrome (AWS), and experience significant morbidity and mortality. In patients with septic shock or at risk for acute respiratory distress syndrome (ARDS), chronic alcohol abuse is associated with increased ARDS and severity of multiple organ dysfunction.1 Among intensive care unit (ICU) patients, those with alcohol dependence have higher morbidity, including septic shock, and higher hospital mortality.2 Patients who experience AWS as a result of alcohol dependence may experience life‐threatening complications, such as seizures and delirium tremens.3,4 In‐hospital mortality from AWS is historically high,5 but with benzodiazepines used in a symptom‐driven manner to treat the complications of alcohol use, hospital mortality rates are more recently reported at 2.4%.6

As inpatient outcomes1,2,7 and hospital mortality810 are negatively affected by alcohol abuse, the post‐hospital course of these patients is also of interest. Specifically, patients are often admitted and readmitted with alcohol‐related diagnoses or AWS to acute care hospitals, but relatively little quantitative data exist on readmission factors in this population.11 Patients readmitted to detoxification units or alcohol and substance abuse units have been studied, and factors associated with readmission include psychiatric disorder,1217 female gender,14,15 and delay in rehabilitation aftercare.18

These results cannot be generalized to patients with AWS who are admitted and readmitted to acute‐care hospitals. First, patients hospitalized for alcohol withdrawal symptoms are often medically ill with more severe symptoms, and more frequent coexisting medical and psychiatric illnesses, that complicate the withdrawal syndrome. Detoxification units and substance abuse units require patients to be medically stable before admission, because they do not have the ability to provide a high level of supervision and treatment. Second, much of what we know regarding risk factors for readmission to detoxification centers and substance abuse units comes from studies of administrative data of the Veterans Health Administration,12,13 Medicare Provider Analysis and Review file,16 privately owned outpatient substance abuse centers,14 and publicly funded detoxification centers.18 These results may be difficult to generalize to other patient populations. Accordingly, the objective of this study was to identify demographic and clinical factors associated with multiple admissions to a general medicine service for treatment of AWS over a 3‐year period. Characterization of these high‐risk patients and their hospital course may help focus intervention and reduce these revolving door admissions.

METHODS

The Mayo Clinic Institutional Review Board deemed the study exempt.

Patient Selection

The study was conducted at an 1157‐bed academic tertiary referral hospital, located in the Midwest, that has approximately 15,000 inpatient admissions to general medicine services annually and serves as the main referral center for the region. Patients included in this study were adults admitted to general medicine services and treated with symptom‐triggered Clinical Institute Withdrawal AssessmentAlcohol Revised (CIWA‐Ar) protocol19 between January 1, 2006 and December 31, 2008. Patients were identified using the Mayo Clinic Quality Improvement Resource Center database, as done in a previous CIWA‐Ar study.20 Patients were excluded if the primary diagnosis was a nonalcohol‐related diagnosis (Figure 1).

Figure 1

Patients were placed in 1 of 2 groups based on number of admissions during the study period, either a single‐admission group or a multiple‐admissions group. While most readmission studies use a 30‐day mark from discharge, we used 3 years to better capture relapse and recidivism in this patient population. The 2 groups were then compared retrospectively. To insure that a single admission was not arbitrarily created by the December 2008 cutoff, we reviewed the single‐admission group for additional admissions through June of 2009. If a patient did have a subsequent admission, then the patient was moved to the multiple‐admissions group.

RESULTS

The CIWA‐Ar protocol was ordered on 1199 admissions during the study period. Of these, 411 (34.3%) admissions were excluded because AWS was not the primary diagnosis, leaving 788 (65.7%) admissions for 322 patients, which formed the study population. Of the 322 patients, 180 (56%) had a single admission and 142 (44%) had multiple admissions.

Univariate analyses of demographic and clinical variables are shown in Tables 1 and 2, respectively. Patients with multiple admissions were more likely divorced (P = 0.028), have a high school education or less (P = 0.002), have a higher CCI score (P < 0.0001), a higher CIWA‐Ar score (max) (P < 0.0001), a higher ALT level (P = 0.050), more psychiatric comorbidity (P < 0.026), and a positive urine drug screen (P < 0.001). Adverse events were not significantly different between the 2 groups (Table 2).

Multivariate logistic model analysis was performed using the variables age, male gender, divorced marital status, high school education or less, CIWA‐Ar score (max), CCI score, psychiatric comorbidity, and positive urine drug screen. With a stepwise elimination process, the final model showed that multiple admissions were associated with high school education or less (P = 0.0071), higher CCI score (P = 0.0010), higher CIWA‐Ar score (max) (P < 0.0001), a positive urine drug screen (P = 0.0002), and psychiatric comorbidity (P = 0.0303) (Table 3).

DISCUSSION

We provide important information regarding identification of individuals at high risk for multiple admissions to general medicine services for treatment of AWS. This study found that patients with multiple admissions for AWS had more medical comorbidity. They had more cases of diabetes mellitus, cardiovascular disease, and cerebrovascular disease, and their CCI scores were higher. They also had higher CIWA‐Ar (max) scores, as well as higher CIWA‐Ar component scores, indicating a more severe withdrawal.

Further, psychiatric comorbidity was also associated with multiple admissions. Consistent with the high prevalence in alcoholic patients, psychiatric comorbidity was common in both patients with a single admission and multiple admissions. We also found that a positive urine drug screen was associated with multiple admissions. Interestingly, few patients in each group had a diagnosis recorded in the medical record of an additional substance abuse disorder, yet 14% of patients with a single admission and 29% of patients with multiple admissions had a positive urine drug screen for a non‐alcohol substance. Psychiatric comorbidity, including additional substance abuse, is a well‐established risk factor for readmission to detoxification centers.1215, 17,22,23 Also, people with either an alcohol or non‐alcohol drug addiction, are known to be 7 times more likely to have another addiction than the rest of the population.24 This study suggests clinicians may underrecognize additional substance abuse disorders which are common in this patient population.

In contrast to studies of patients readmitted to detoxification units and substance abuse units,14,15,18,22 we found level of education, specifically a high school education or less, to be associated with multiple admissions. In a study of alcoholics, Greenfield and colleagues found that lower education in alcoholics predicts shorter time to relapse.25 A lack of education may result in inadequate healthcare literacy. Poor health behavior choices that follow may lead to relapse and subsequent admissions for AWS. With respect to other demographic variables, patients in our study population were predominantly men, which is not surprising. Gender differences in alcoholism are well established, with alcohol abuse and dependence more prevalent in men.26 We did not find gender associated with multiple admissions.

Our findings have management and treatment implications. First, providers who care for patients with AWS should not simply focus on treating withdrawal signs and symptoms, but also screen for and address other medical issues, which may not be apparent or seem stable at first glance. While a comorbid medical condition may not be the primary reason for hospital admission, comorbid medical conditions are known to be a source of psychological distress27 and have a negative effect on abstinence. Second, all patients should be screened for additional substance abuse. Initial laboratory testing should include a urine drug screen. Third, before discharging the patient, providers should establish primary care follow‐up for continued surveillance of medical issues. There is evidence that primary care services are predictive of better substance abuse treatment outcomes for those with medical problems.28,29

Finally, inpatient psychiatric consultation, upon admission, is essential for several reasons. First, the psychiatric team can help with initial management and treatment of the alcohol withdrawal regardless of stage and severity, obtain a more comprehensive psychiatric history, and assess for the presence of psychiatric comorbidities that may contribute to, aggravate, or complicate the clinical picture. The team can also address other substance abuse issues when detected by drug screen or clinical history. The psychiatric team, along with chemical‐dependency counselors and social workers, can provide valuable input regarding chemical‐dependency resources available on discharge and help instruct the patient in healthy behaviors. Because healthcare illiteracy may be an issue in this patient population, these instructions should be tailored to the patient's educational level. Prior to discharge, the psychiatry team, social workers, or chemical‐dependency counselors can also assist with, or arrange, rehabilitation aftercare for patients. Recent work shows that patients were less likely to be readmitted to crisis detoxification if they entered rehabilitation care within 3 days of discharge.18

Our study has significant limitations. This study was performed with data at a single academic medical center with an ethnically homogeneous patient population, limiting the external validity of its results. Because this is a retrospective study, data analyses are limited by the quality and accuracy of data in the electronic medical record. Also, our follow‐up period may not have been long enough to detect additional admissions, and we did not screen for patient admissions prior to the study period. By limiting data collection to admissions for AWS to general medical services, we may have missed cases of AWS when admitted for other reasons or to subspecialty services, and we may have missed severe cases requiring admission to an intensive care unit. While we believe we were able to capture most admissions, we may underreport this number since we cannot account for those events that may have occurred at other facilities and locations. Lastly, without a control group, this study is limited in its ability to show an association between any variable and readmission.

In our study, 142 patients accounted for 608 admissions during the 3‐year study period, which speaks to the high recidivism rates for patients with AWS. This disease is associated with high morbidity, high medical costs, and high utilization of healthcare. Our study provides insight regarding identification of patients at high risk of multiple admissions with respect to demographic (lower level of education) and clinical characteristics (worse withdrawal severity, more medical and psychiatric comorbidity, and polysubstance abuse). We believe collaboration between social services, chemical‐dependency counselors, psychiatry, and medicine is necessary to effectively treat this population of patients and assist with the crucial transition to the outpatient setting. Future studies should include key social factors, such as health literacy in the readmission risk assessment, as well as primary care follow‐up and rehabilitation aftercare.

Many patients are admitted and readmitted to acute care hospitals with alcohol‐related diagnoses, including alcohol withdrawal syndrome (AWS), and experience significant morbidity and mortality. In patients with septic shock or at risk for acute respiratory distress syndrome (ARDS), chronic alcohol abuse is associated with increased ARDS and severity of multiple organ dysfunction.1 Among intensive care unit (ICU) patients, those with alcohol dependence have higher morbidity, including septic shock, and higher hospital mortality.2 Patients who experience AWS as a result of alcohol dependence may experience life‐threatening complications, such as seizures and delirium tremens.3,4 In‐hospital mortality from AWS is historically high,5 but with benzodiazepines used in a symptom‐driven manner to treat the complications of alcohol use, hospital mortality rates are more recently reported at 2.4%.6

As inpatient outcomes1,2,7 and hospital mortality810 are negatively affected by alcohol abuse, the post‐hospital course of these patients is also of interest. Specifically, patients are often admitted and readmitted with alcohol‐related diagnoses or AWS to acute care hospitals, but relatively little quantitative data exist on readmission factors in this population.11 Patients readmitted to detoxification units or alcohol and substance abuse units have been studied, and factors associated with readmission include psychiatric disorder,1217 female gender,14,15 and delay in rehabilitation aftercare.18

These results cannot be generalized to patients with AWS who are admitted and readmitted to acute‐care hospitals. First, patients hospitalized for alcohol withdrawal symptoms are often medically ill with more severe symptoms, and more frequent coexisting medical and psychiatric illnesses, that complicate the withdrawal syndrome. Detoxification units and substance abuse units require patients to be medically stable before admission, because they do not have the ability to provide a high level of supervision and treatment. Second, much of what we know regarding risk factors for readmission to detoxification centers and substance abuse units comes from studies of administrative data of the Veterans Health Administration,12,13 Medicare Provider Analysis and Review file,16 privately owned outpatient substance abuse centers,14 and publicly funded detoxification centers.18 These results may be difficult to generalize to other patient populations. Accordingly, the objective of this study was to identify demographic and clinical factors associated with multiple admissions to a general medicine service for treatment of AWS over a 3‐year period. Characterization of these high‐risk patients and their hospital course may help focus intervention and reduce these revolving door admissions.

METHODS

The Mayo Clinic Institutional Review Board deemed the study exempt.

Patient Selection

The study was conducted at an 1157‐bed academic tertiary referral hospital, located in the Midwest, that has approximately 15,000 inpatient admissions to general medicine services annually and serves as the main referral center for the region. Patients included in this study were adults admitted to general medicine services and treated with symptom‐triggered Clinical Institute Withdrawal AssessmentAlcohol Revised (CIWA‐Ar) protocol19 between January 1, 2006 and December 31, 2008. Patients were identified using the Mayo Clinic Quality Improvement Resource Center database, as done in a previous CIWA‐Ar study.20 Patients were excluded if the primary diagnosis was a nonalcohol‐related diagnosis (Figure 1).

Figure 1

Patients were placed in 1 of 2 groups based on number of admissions during the study period, either a single‐admission group or a multiple‐admissions group. While most readmission studies use a 30‐day mark from discharge, we used 3 years to better capture relapse and recidivism in this patient population. The 2 groups were then compared retrospectively. To insure that a single admission was not arbitrarily created by the December 2008 cutoff, we reviewed the single‐admission group for additional admissions through June of 2009. If a patient did have a subsequent admission, then the patient was moved to the multiple‐admissions group.

RESULTS

The CIWA‐Ar protocol was ordered on 1199 admissions during the study period. Of these, 411 (34.3%) admissions were excluded because AWS was not the primary diagnosis, leaving 788 (65.7%) admissions for 322 patients, which formed the study population. Of the 322 patients, 180 (56%) had a single admission and 142 (44%) had multiple admissions.

Univariate analyses of demographic and clinical variables are shown in Tables 1 and 2, respectively. Patients with multiple admissions were more likely divorced (P = 0.028), have a high school education or less (P = 0.002), have a higher CCI score (P < 0.0001), a higher CIWA‐Ar score (max) (P < 0.0001), a higher ALT level (P = 0.050), more psychiatric comorbidity (P < 0.026), and a positive urine drug screen (P < 0.001). Adverse events were not significantly different between the 2 groups (Table 2).

Multivariate logistic model analysis was performed using the variables age, male gender, divorced marital status, high school education or less, CIWA‐Ar score (max), CCI score, psychiatric comorbidity, and positive urine drug screen. With a stepwise elimination process, the final model showed that multiple admissions were associated with high school education or less (P = 0.0071), higher CCI score (P = 0.0010), higher CIWA‐Ar score (max) (P < 0.0001), a positive urine drug screen (P = 0.0002), and psychiatric comorbidity (P = 0.0303) (Table 3).

DISCUSSION

We provide important information regarding identification of individuals at high risk for multiple admissions to general medicine services for treatment of AWS. This study found that patients with multiple admissions for AWS had more medical comorbidity. They had more cases of diabetes mellitus, cardiovascular disease, and cerebrovascular disease, and their CCI scores were higher. They also had higher CIWA‐Ar (max) scores, as well as higher CIWA‐Ar component scores, indicating a more severe withdrawal.

Further, psychiatric comorbidity was also associated with multiple admissions. Consistent with the high prevalence in alcoholic patients, psychiatric comorbidity was common in both patients with a single admission and multiple admissions. We also found that a positive urine drug screen was associated with multiple admissions. Interestingly, few patients in each group had a diagnosis recorded in the medical record of an additional substance abuse disorder, yet 14% of patients with a single admission and 29% of patients with multiple admissions had a positive urine drug screen for a non‐alcohol substance. Psychiatric comorbidity, including additional substance abuse, is a well‐established risk factor for readmission to detoxification centers.1215, 17,22,23 Also, people with either an alcohol or non‐alcohol drug addiction, are known to be 7 times more likely to have another addiction than the rest of the population.24 This study suggests clinicians may underrecognize additional substance abuse disorders which are common in this patient population.

In contrast to studies of patients readmitted to detoxification units and substance abuse units,14,15,18,22 we found level of education, specifically a high school education or less, to be associated with multiple admissions. In a study of alcoholics, Greenfield and colleagues found that lower education in alcoholics predicts shorter time to relapse.25 A lack of education may result in inadequate healthcare literacy. Poor health behavior choices that follow may lead to relapse and subsequent admissions for AWS. With respect to other demographic variables, patients in our study population were predominantly men, which is not surprising. Gender differences in alcoholism are well established, with alcohol abuse and dependence more prevalent in men.26 We did not find gender associated with multiple admissions.

Our findings have management and treatment implications. First, providers who care for patients with AWS should not simply focus on treating withdrawal signs and symptoms, but also screen for and address other medical issues, which may not be apparent or seem stable at first glance. While a comorbid medical condition may not be the primary reason for hospital admission, comorbid medical conditions are known to be a source of psychological distress27 and have a negative effect on abstinence. Second, all patients should be screened for additional substance abuse. Initial laboratory testing should include a urine drug screen. Third, before discharging the patient, providers should establish primary care follow‐up for continued surveillance of medical issues. There is evidence that primary care services are predictive of better substance abuse treatment outcomes for those with medical problems.28,29

Finally, inpatient psychiatric consultation, upon admission, is essential for several reasons. First, the psychiatric team can help with initial management and treatment of the alcohol withdrawal regardless of stage and severity, obtain a more comprehensive psychiatric history, and assess for the presence of psychiatric comorbidities that may contribute to, aggravate, or complicate the clinical picture. The team can also address other substance abuse issues when detected by drug screen or clinical history. The psychiatric team, along with chemical‐dependency counselors and social workers, can provide valuable input regarding chemical‐dependency resources available on discharge and help instruct the patient in healthy behaviors. Because healthcare illiteracy may be an issue in this patient population, these instructions should be tailored to the patient's educational level. Prior to discharge, the psychiatry team, social workers, or chemical‐dependency counselors can also assist with, or arrange, rehabilitation aftercare for patients. Recent work shows that patients were less likely to be readmitted to crisis detoxification if they entered rehabilitation care within 3 days of discharge.18

Our study has significant limitations. This study was performed with data at a single academic medical center with an ethnically homogeneous patient population, limiting the external validity of its results. Because this is a retrospective study, data analyses are limited by the quality and accuracy of data in the electronic medical record. Also, our follow‐up period may not have been long enough to detect additional admissions, and we did not screen for patient admissions prior to the study period. By limiting data collection to admissions for AWS to general medical services, we may have missed cases of AWS when admitted for other reasons or to subspecialty services, and we may have missed severe cases requiring admission to an intensive care unit. While we believe we were able to capture most admissions, we may underreport this number since we cannot account for those events that may have occurred at other facilities and locations. Lastly, without a control group, this study is limited in its ability to show an association between any variable and readmission.

In our study, 142 patients accounted for 608 admissions during the 3‐year study period, which speaks to the high recidivism rates for patients with AWS. This disease is associated with high morbidity, high medical costs, and high utilization of healthcare. Our study provides insight regarding identification of patients at high risk of multiple admissions with respect to demographic (lower level of education) and clinical characteristics (worse withdrawal severity, more medical and psychiatric comorbidity, and polysubstance abuse). We believe collaboration between social services, chemical‐dependency counselors, psychiatry, and medicine is necessary to effectively treat this population of patients and assist with the crucial transition to the outpatient setting. Future studies should include key social factors, such as health literacy in the readmission risk assessment, as well as primary care follow‐up and rehabilitation aftercare.